TAMI LEE: Open Payments
NPI 1982665808 · ROXBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$638 in 35 payments from 15 companies in 2025. Trend: 2023 $430 · 2024 $1,074 · 2025 $638
Food & beverage: $638
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $135 |
| Corcept Therapeutics | 3 | $80 |
| ABBVIE INC. | 4 | $78 |
| Lilly USA, LLC | 4 | $77 |
| Novo Nordisk Inc | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Amgen Inc. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Medtronic, Inc. | 1 | $24 |
Products named: NURTEC ODT, Korlym, MOUNJARO, VRAYLAR, JARDIANCE, CAPLYTA, FANAPT, INCEPTIV.
Industry payments across NC — which companies pay providers there.
